Myriad Genetics, Inc.MYGNNASDAQ
Loading
Year-over-year earnings per share growth rate
Percentile
P74
Within normal range
vs 2Y Ago
1.4x
Solid growth
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 72.41% |
| Q3 2025 | 91.88% |
| Q2 2025 | -324445.45% |
| Q1 2025 | 99.77% |
| Q4 2024 | -95.83% |
| Q3 2024 | 41.46% |
| Q2 2024 | -41.38% |
| Q1 2024 | 19.44% |
| Q4 2023 | 52.00% |
| Q3 2023 | 47.18% |
| Q2 2023 | -111.94% |
| Q1 2023 | -28.85% |
| Q4 2022 | -20.93% |
| Q3 2022 | -138.89% |
| Q2 2022 | 30.77% |
| Q1 2022 | -173.40% |
| Q4 2021 | -130.68% |
| Q3 2021 | 609.03% |
| Q2 2021 | 88.29% |
| Q1 2021 | 11.86% |
| Q4 2020 | -195.00% |
| Q3 2020 | 72.97% |
| Q2 2020 | 52.26% |
| Q1 2020 | -1309.09% |
| Q4 2019 | 60.71% |
| Q3 2019 | -389.51% |
| Q2 2019 | -163.56% |
| Q1 2019 | 125.00% |
| Q4 2018 | 516.67% |
| Q3 2018 | -105.05% |
| Q2 2018 | 18.75% |
| Q1 2018 | -65.22% |
| Q4 2017 | -61.02% |
| Q3 2017 | 521.05% |
| Q2 2017 | 216.67% |
| Q1 2017 | -33.33% |
| Q4 2016 | 617.24% |
| Q3 2016 | -105.27% |
| Q2 2016 | -32.65% |
| Q1 2016 | 13.95% |